---
schema_version: "secwatch.filing_event.v1"
accession: "0000097745-22-000022"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2022-04-28T23:59:59+00:00"
generated_at: "2026-06-26T03:52:06.586483+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher Q1 revenue $11.82B (+19%), adjusted EPS $7.25; raises dividend 15%

## Summary
- GAAP EPS $5.61 vs $5.88 last year; adjusted EPS $7.25 vs $7.21.
- Core organic growth 16%; COVID-19 testing revenue $1.68B.
- Repurchased $2.0B of stock and increased dividend by 15%.
- PPD clinical research business integration proceeding smoothly.
- Moderna entered 15-year strategic collaboration for mRNA manufacturing.

## SEC filing metadata
- accession: 0000097745-22-000022
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2022-04-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000009774522000022/0000097745-22-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000009774522000022/tmo-20220428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000097745-22-000022
- JSON: https://secwatch.observer/filing/0000097745-22-000022.json
- Plain text: https://secwatch.observer/filing/0000097745-22-000022.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.